Novartis Drug Becomes First Malaria Therapy for Newborns and Infants
Novartis malaria drug Coartem has expanded its approval to include babies. The combination drug, originally…
Novartis Drug Becomes First Malaria Therapy for Newborns and Infants
Novartis malaria drug Coartem has expanded its approval to include babies. The combination drug, originally formulated as a tablet, has a new dose strength and formulation designed for treating newborns and young infants who develop malarial infections. The post Novartis Drug Becomes First Malaria Therapy for Newborns and Infants appeared first on MedCity News.
Quotation of the Day
Things turn out best for the people who make the best of the way things turn out. John Wooden
The 3 Best Options to Buy Telemedicine Carts for Neurology Care
[Sponsored] Neurologists and health care practitioners must evolve with the world. Telemedicine carts assist in this evolution by serving as an intermediary between patients and doctors. The post The 3 Best Options to Buy Telemedicine Carts for Neurology Care appeared first on MedCity News.
The Future of Surgery: Bridging Innovation and Collaboration
The industry needs smart conversations that challenge assumptions and invite the full spectrum of voices to the table to ensure technology evolves in a way that’s not only clinically sound, but ethically aligned with what patients and providers need most. The post The Future of Surgery: Bridging Innovation and Collaboration appeared first on MedCity News.
When Cost Blocks Care: Why Medication Affordability Is the Next Frontier in Patient Care
Every day, patients are making agonizing choices to skip medications due to cost, and the fallout is evident in worsening health and avoidable hospitalizations. Health systems are in a prime position to break this cycle by acting as advocates for their patients’ financial as well as physical well-being. The post When Cost Blocks Care: Why Medication…
Broadening Biomarker Validation for Alzheimer’s Disease Diagnosis Globally
Demonstrating the clinical utility and cost-effectiveness of innovative blood-based biomarker tests can help pave the way for making timely AD diagnosis and proactive care the norm. The post Broadening Biomarker Validation for Alzheimer’s Disease Diagnosis Globally appeared first on MedCity News.
Henry Ford, the Model T, and Digital Health
By TREVOR VAN MIERLO Most of us know the story of the Model T – but what’s often overlooked is how it applies to other industries, especially digital health. Let’s revisit: In the early 1900s cars were custom built. You’d meet with a consultant, design the car, place your order, and wait for months for…
Workplace Mental Health at Risk as Key Federal Agency Faces Cuts
In Connecticut, construction workers in the Local 478 union who complete addiction treatment are connected with a recovery coach who checks in daily, attends recovery meetings with them, and helps them navigate the return to work for a year. In Pennsylvania, doctors applying for credentials at Geisinger hospitals are not required to answer intrusive questions…
In a Nation Growing Hostile Toward Drugs and Homelessness, Los Angeles Tries Leniency
LOS ANGELES — Inside a bright new building in the heart of Skid Row, homeless people hung out in a canopy-covered courtyard — some waiting to take a shower, do laundry, or get medication for addiction treatment. Others relaxed on shaded grass and charged their phones as an intake line for housing grew more crowded….
Digital Health Funding in H1 2025: Market Stabilizes, AI Dominates and Exits Return
Digital health funding held steady in the first half of 2025, with AI-focused startups capturing the majority of capital and driving rapid adoption among providers. The digital health space also saw two long-awaited IPOs as well as rising M&A activity, which are two signals of market maturity — but looming policy shifts may challenge long-term…
